China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 64,941 | 53,844 | 8,815 | 5,010 | 4,268 |
| Receivables | 12,862 | 4,176 | 817 | 1,032 | 4,360 |
| Inventories | 52,301 | 35,133 | 14,949 | 9,505 | 6,117 |
| Other current assets | 1,861 | 1,054 | 0 | 41 | 81 |
| TOTAL | $132,820 | $95,506 | $25,196 | $15,727 | $15,541 |
| Non-Current Assets | |||||
| PPE Net | 39,512 | 28,873 | 19,299 | 15,434 | 7,438 |
| Investments And Advances | 7,297 | 6,627 | 6,534 | 0 | 0 |
| Intangibles | 37,039 | 38,381 | 1,003 | 916 | 718 |
| Other Non-Current Assets | 4,255 | 3,224 | 15,138 | 1,228 | 778 |
| TOTAL | $88,102 | $77,106 | $41,974 | $17,578 | $8,934 |
| Total Assets | $220,922 | $172,612 | $67,169 | $33,305 | $24,475 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,034 | 8,054 | 773 | 1,408 | 3,240 |
| Accounts payable and accrued liabilities | 29,192 | 28,354 | 12,973 | 4,386 | 4,574 |
| Accrued Expenses | N/A | 2,069 | N/A | N/A | N/A |
| Other current liabilities | 29,217 | 36,530 | 1,092 | 399 | 370 |
| TOTAL | $71,446 | $83,869 | $18,927 | $6,578 | $8,799 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 5,868 | N/A | N/A |
| Other Non-Current Liabilities | -20,116 | -16,292 | -2,978 | -1,546 | -663 |
| TOTAL | $4,432 | $4,599 | $6,193 | $446 | $641 |
| Total Liabilities | $75,878 | $88,468 | $25,121 | $7,024 | $9,440 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 24,351 | N/A | N/A | 21,435 | N/A |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 55,739 | 24,196 | 15,392 | 6,462 | 17 |
| Other shareholders' equity | 53,868 | 38,674 | 15,955 | 10,429 | 5,627 |
| TOTAL | $145,044 | $84,143 | $42,049 | $26,282 | $15,034 |
| Total Liabilities And Equity | $220,922 | $172,612 | $67,169 | $33,305 | $24,475 |